QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chuang, D. T. Articles by Wynn, R. M. Search for Related Content PubMed PubMed Citation Articles by Chuang, D. T. Articles by Wynn, R. M.

---

Branched-Chain Amino Acids: Metabolism, Physiological Function, and Application: Session II

Lessons from Genetic Disorders of Branched-Chain Amino Acid Metabolism^1–3,

Departments of Biochemistry and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9038

⁴ To whom correspondence should be addressed. E-mail: david.chuang{at}utsouthwestern.edu.

ABSTRACT

Genetic disorders of BCAA metabolism produce amino acidopathies and various forms of organic aciduria with severe clinical consequences. A metabolic block in the oxidative decarboxylation of BCAA caused by mutations in the mitochondrial branched-chain -keto acid dehydrogenase complex (BCKDC) results in Maple Syrup Urine Disease (MSUD) or branched-chain ketoaciduria. There are presently five known clinical phenotypes for MSUD, i.e., classic, intermediate, intermittent, thiamin-responsive, and dihydrolipoamide dehydrogenase (E3)-deficient, based on severity of the disease, response to thiamin therapy, and the gene locus affected. Reduced glutamate, glutamine, and -aminobutyrate concentrations induced by the accumulation of branched-chain -ketoacids in the brain cortex of affected children and neonatal polled Hereford calves are considered the cause of MSUD encephalopathies. The long-term restriction of BCAA intake in diets and orthotopic liver transplantation have proven effective in controlling plasma BCAA levels and mitigating some of the above neurological manifestations. To date, 100 mutations have been identified in four (branched-chain -ketoacid decarboxylase/dehydrogenase [E1], E1ß, dihydrolipoyl transacylase [E2], and E3) of the six genes that encode the human BCKDC catalytic machine. We have documented a strong correlation between the presence of mutant E2 proteins and the thiamin-responsive MSUD phenotype. We show that the normal E1 component possesses residual decarboxylase activity, which is augmented by the binding to a mutant E2 protein in the presence of the E1 cofactor thiamin diphosphate. Our results provide a biochemical model for the effectiveness of thiamin therapy to thiamin-responsive MSUD patients.

KEY WORDS: • branched-chain amino acid metabolism • Maple Syrup Urine Disease • E2 deficiency • thiamin-responsive MSUD • thiamin supplementation • branched-chain -ketoacid dehydrogenase • thiamin diphosphate

This article has been cited by other articles:

				C. Gelling, I. W. Dawes, N. Richhardt, R. Lill, and U. Muhlenhoff Mitochondrial Iba57p Is Required for Fe/S Cluster Formation on Aconitase and Activation of Radical SAM Enzymes Mol. Cell. Biol., March 1, 2008; 28(5): 1851 - 1861. [Abstract] [Full Text] [PDF]

				O. Onder, H. Yoon, B. Naumann, M. Hippler, A. Dancis, and F. Daldal Modifications of the Lipoamide-containing Mitochondrial Subproteome in a Yeast Mutant Defective in Cysteine Desulfurase Mol. Cell. Proteomics, August 1, 2006; 5(8): 1426 - 1436. [Abstract] [Full Text] [PDF]